İLHAN, O. Et Al. 2019. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?. 2019 American Society of Clinical Oncology (ASCO) Annual Meeting .

İLHAN, O., CENGİZ SEVAL, G., TOPRAK, S. K., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2019). Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients? . 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

İLHAN, Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?," 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, 2019

İLHAN, OSMAN Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." 2019 American Society of Clinical Oncology (ASCO) Annual Meeting , 2019

İLHAN, O. Et Al. (2019) . "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." 2019 American Society of Clinical Oncology (ASCO) Annual Meeting .

@conferencepaper{conferencepaper, author={ OSMAN İLHAN Et Al. }, title={Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?}, congress name={2019 American Society of Clinical Oncology (ASCO) Annual Meeting}, city={}, country={}, year={2019}}